1H3 Stock Overview
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Clearbridge Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.01 |
| 52 Week High | S$0.031 |
| 52 Week Low | S$0.009 |
| Beta | 0.65 |
| 1 Month Change | 0% |
| 3 Month Change | -28.57% |
| 1 Year Change | -65.52% |
| 3 Year Change | -93.51% |
| 5 Year Change | -94.25% |
| Change since IPO | -96.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1H3 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -16.7% | -1.7% | -1.7% |
| 1Y | -65.5% | -25.7% | -7.9% |
Return vs Industry: 1H3 underperformed the SG Healthcare industry which returned -25.7% over the past year.
Return vs Market: 1H3 underperformed the SG Market which returned -7.9% over the past year.
Price Volatility
| 1H3 volatility | |
|---|---|
| 1H3 Average Weekly Movement | 18.2% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 15.8% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 1H3's share price has been volatile over the past 3 months.
Volatility Over Time: 1H3's weekly volatility has increased from 13% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 121 | Jeremy Yee | www.clearbridgehealth.com |
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services.
Clearbridge Health Limited Fundamentals Summary
| 1H3 fundamental statistics | |
|---|---|
| Market cap | S$6.19m |
| Earnings (TTM) | -S$32.20m |
| Revenue (TTM) | S$11.49m |
0.5x
P/S Ratio-0.2x
P/E RatioIs 1H3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1H3 income statement (TTM) | |
|---|---|
| Revenue | S$11.49m |
| Cost of Revenue | S$5.40m |
| Gross Profit | S$6.10m |
| Other Expenses | S$38.29m |
| Earnings | -S$32.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 53.05% |
| Net Profit Margin | -280.24% |
| Debt/Equity Ratio | 38.2% |
How did 1H3 perform over the long term?
See historical performance and comparison